ClariVest Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

ClariVest Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-14,434	Closed	-$771K	–	733
2016 Q1	$771K	Buy	14,434 +614	+4%	+$45.3K	0.02%	314
2015 Q4	$1.56M	Sell	13,820 -318	-2%	-$35K	0.04%	222
2015 Q3	$1.66M	Buy	+14,138	New	+$1.85M	0.05%	208

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

ClariVest Asset Management's ANAC Position: Q2 2016 in Review

ClariVest Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 14,434 shares — an estimated $771K sold.

ClariVest Asset Management first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $1.66M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

ClariVest Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
ClariVest Asset Management sold 14,434 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $771K.
ClariVest Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
ClariVest Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $1.66M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on ClariVest Asset Management's 13F filing for Q2 2016, filed 28 Jul 2016.